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Theoretical Considerations Regarding the Study
“Alpha-B Crystallin Gene (CRYAB) Mutation Causes
Dominant Congenital Posterior Polar Cataract in
Humans”
To the Editor:
In a recently published article (Berry et al. 2001), it was
shown that a novel eye lens crystallin mutation of the
aB gene (CRYAB) caused dominant well-demarcated
congenital posterior polar cataract in a four-generation
family of English descent. The described perinatal non-
progressive opacity was confined to the posterior pole
of the lens and was 0.5–3 mm in diameter. Sequence
analysis of the CRYAB gene revealed a deletionmutation
(450delA) that cosegregated with the disease in the fam-
ily. It was speculated that cataract in this family may
have resulted from an increasing tendency of the mutant
polypeptide to aggregate and/or from loss of the chap-
erone-like activity of aB-crystallin, since its protective
role in suppressing aggregation of denatured proteins
was diminished or lost (Berry et al. 2001).
It is known, however, that during normal lens devel-
opment, a-crystallins are the first crystallins synthesized
in the lens during embryogenesis (Zwaan 1983) and that
the lens tissue grows throughout the life span of an in-
dividual: new lens fibers develop, and crystallins, in-
cluding aA- and aB-crystallins, are synthesized contin-
uously. The latter are the most abundant soluble
crystallins in the lens and play an important role inmain-
taining the transparency of the lens (Delaye and Tardieu
1983). If the defective gene CRYAB is responsible for
the perinatal posterior nonspreading opacity of the lens,
then synthesis of defective proteins should have ceased
before and after the perinatal life period, which presumes
a temporary self-recovery of the mutation. If, however,
the described autosomal dominant perinatal posterior
lens opacity is caused solely by the synthesized defective
protein, then lens opacity should have also been detect-
able in the lens embryonic nucleus and should have ex-
panded all over the lens during the later life of the in-
dividual, which did not occur. Therefore, it can be
supposed that the described defective gene, situated in
the CRYAB locus (Berry et al. 2001), may not be the
cause for posterior polar nonspreading opacity, since the
lens embryonic nucleus and the developing postnatal
lens tissue were transparent. Therefore, it is suggested
that the described opacities might depend on the tem-
porary persistent primary vitreous, located in Cloquet’s
canal after the regression of the hyaloid artery during
the last trimester of fetal development. Cloquet’s canal
extends from the optic cup, through the vitreous, to the
lens posterior pole. Evidently, compared with the sur-
rounding secondary gel vitreous, the watery content of
the temporary persistent primary vitreous facilitates ab-
normal metabolism of the posterior lens, enabling os-
motic and oxidative stresses (Ohta et al. 1999) to reach
the lens posterior pole, where they can affect it and cause
posterior lens opacity. The localization and size of the
described opacity fits well with that of the distal orifice
of Cloquet’s canal. The fact that the opaque plaque on
the lens posterior pole did not expand, irrespective of
the persistence of CRYAB gene mutation, serves as
strong evidence suggesting that the described novel mu-
tation might be related to the facilitated perinatal me-
tabolism of some substances or to oxidative stress
through Cloquet’s canal to the lens posterior pole, re-
sulting in the posterior polar opacity. Thus, the deletion
mutation might be wholly responsible for the retarded
regression of the primary vitreous. The absence of the
other ocular or systemic abnormalities in this family his-
tory supports this hypothesis.
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Reply to Veromann
To the Editor:
We thank Dr. Siiri Veromann (Veromann 2002 [in this
issue]) for the interest shown in our article (Berry et al.
2001). Dr. Veromann has highlighted the fact that it is
difficult to explain why a mutation in CRYAB should
give rise to a discrete opacity at the posterior pole of
the lens, since a-crystallin continues to be synthesized
throughout life. Dr. Veromann suggests that the poste-
rior polar phenotype may occur secondary to an effect
on the regression of the primary vitreous.
The mechanisms by which precise genetic mutations
give rise to a specific lens phenotype are ill understood.
We know that mutations in different genes may give rise
to an identical lens phenotype, and we also know that
different mutations within the same gene may give rise
to very different patterns of lens opacification. Posterior
polar cataract is itself genetically heterogeneous (Rich-
ards et al. 1984; Ionides et al. 1997; Yamada et al. 2000).
Such genetic and allelic heterogeneity is common in other
inherited eye disorders, particularly in retinal dystro-
phies (Briggs et al. 2001; Sohocki et al. 2001). It remains
a challenge to identify the mechanism by which specific
mutations give rise to regional opacification within the
lens.
In our article, we suggested that the CRYAB mutation
could give rise to posterior polar cataract by two possible
mechanisms: either by impaired chaperone-like function
or by increased tendency of the mutant polypeptides to
aggregate as a direct effect of abnormal a-crystallin struc-
ture. Studies of the temporal and spatial distribution of
the aA- and aB-crystallin in the human lens suggest that
they are expressed ubiquitously, but their expression var-
ies at different time points during human lens develop-
ment. For instance, aB-crystallin is expressed in the lens
placode at Carnegie stage 13, but by stage 15 the lens
vesicle is intensely positive for both aA- and aB-crystallin
(Oguni et al. 1994). The effects of the mutant protein
could be manifested early in human lens development,
but, of course, aB-crystallin is also widely expressed in
many other cell types, including muscle, epithelial, and
endothelial cells, although the lens is the tissue that ex-
presses the highest physiological concentrations of these
proteins. It is conceivable, therefore, that the reported
mutation in CRYAB could have produced other clinical
symptoms, and we were aware of this possibility. Indeed,
cardiac muscle expresses high levels of aB-crystallin (Kato
et al. 1991), but the family history and clinical analysis
failed to identify any cardiac problems.We suggest, there-
fore, that the effects of the reported mutation are most
likely restricted to the lens.
Impaired chaperone function and/or the increased ten-
dency of the mutant aB-crystallin polypeptide to aggre-
gate may affect the internal structure of lens fibers so
that opacification occurs. The subcapsular posterior re-
gion of the lens is the one where a-crystallin polypeptides
are most highly phosphorylated, at least in the bovine
lens (Chiesa et al. 1989). It is also a lens region where
there are functionally important cytoskeletal elements
that utilize aB-crystallin to function properly (Quinlan
and Prescott, in press). Phosphorylation modulates the
oligomerization status and function of small heat-shock
proteins and their interaction with the cytoskeleton, and
so it is possible to rationalize a localized cataract at the
lens posterior as the characteristic phenotypic manifes-
tation of this CRYAB mutation.
Dr. Veromann suggests another mechanism to account
for the position of the lens opacity. The hypothesis states
that the mutation impairs regression of the primary vit-
reous and that this may result in posterior polar cataract.
Lack of regression of the primary vitreous (or persistent
hyperplastic primary vitreous [PHPV]) is associated with
posterior polar cataract in humans, but the disorder is
usually unilateral and associated with other developmen-
tal abnormalities of the eye. A family with autosomal
recessive inherited nonsyndromic bilateral PHPV has
shown linkage to a 13-cM region on chromosome 10
(Khaliq et al. 2001). However, in this family, posterior
polar cataract was not a consistent feature. The associ-
ation between PHPV and posterior polar cataract has
been reported in mice (Colitz et al. 2000), but, again,
there are other developmental abnormalities, including
persistent tunica vasculosa lentis, detached retina, and an-
terior segment abnormalities.We have been unable to find
any literature relating to a role for aB-crystallin in the
regression of the primary vitreous, but, given the wide-
spread expression aB-crystallin transcripts in the devel-
oping eye, it remains a possibility that it may influence
regression of the primary vitreous. However, given the
current state of knowledge of its function, it is difficult
to identify a plausible biological mechanism by which a
mutation in aB-crystallin would result in failure of re-
